Literature DB >> 1372560

Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.

J Morrison1, J Elvin, F Latron, F Gotch, R Moots, J L Strominger, A McMichael.   

Abstract

Influenza matrix peptide 58-66 is shown to be the optimal nonamer for binding to HLA-A2 and presentation to cytotoxic T lymphocytes (CTL). If titered out to 2 x 10(-10) - 4 x 10(-10) M in CTL-mediated lysis assays and to 3 x 10(-9) M in an HLA-A2 assembly-stabilization assay in cell lysates. The peptide was shown to make probable contacts with its carboxy terminus close to residue 116 in the floor of the cleft of HLA-A2, close to the F pocket. The side chain of the amino-terminal amino acid was unimportant, but its free amino and carbonyl groups in the A pocket appeared important in optimizing peptide presentation. The B pocket probably accommodates the side chain of residue 2 (isoleucine) and was shown to be critical in peptide presentation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372560     DOI: 10.1002/eji.1830220404

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

1.  The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants.

Authors:  Galina V Petrova; Elena N Naumova; Jack Gorski
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

Review 2.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 3.  Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1992

Review 4.  Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity.

Authors:  Katherine Kedzierska; Nicole L La Gruta; John Stambas; Stephen J Turner; Peter C Doherty
Journal:  Mol Immunol       Date:  2007-08-24       Impact factor: 4.407

5.  The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Analysis of a naturally occurring HLA class I-restricted viral epitope.

Authors:  K Falk; O Rötzschke; S Stevanović; V Gnau; K Sparbier; G Jung; H G Rammensee; P Walden
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

7.  Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.

Authors:  R Maier; K Falk; O Rötzschke; B Maier; V Gnau; S Stevanović; G Jung; H G Rammensee; A Meyerhans
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.

Authors:  Rieuwert Hoppes; Rimke Oostvogels; Jolien J Luimstra; Kim Wals; Mireille Toebes; Laura Bies; Reggy Ekkebus; Pramila Rijal; Patrick H N Celie; Julie H Huang; Maarten E Emmelot; Robbert M Spaapen; Henk Lokhorst; Ton N M Schumacher; Tuna Mutis; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

9.  Bacterial Superantigens Expand and Activate, Rather than Delete or Incapacitate, Preexisting Antigen-Specific Memory CD8+ T Cells.

Authors:  Courtney E Meilleur; Christine M Wardell; Tina S Mele; Jimmy D Dikeakos; Jack R Bennink; Hong-Hua Mu; John K McCormick; S M Mansour Haeryfar
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

10.  The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.

Authors:  Joanna A L Choo; Jingxian Liu; Xinyu Toh; Gijsbert M Grotenbreg; Ee Chee Ren
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.